| Íàèìåíîâàíèå | Ïðîèçâîäèòåëü | Öåíà $ | Öåíà ðóá
|
|---|
| ÄÅÐÈÍÀÒ (Ð-Ð Ä/ÈÍ. 1,5% 5ÌË ÔË ¹5 ) | ÒÅÕÍÎÌÅÄÑÅÐÂÈÑ ÔÏ ÇÀÎ ÐÎÑÑÈß | | 1190
|
| ÄÅÐÌÎÂÅÉÒ (ÊÐÅÌ 25 Ã ) | GLAXO WELLCOME ÂÅËÈÊÎÁÐÈÒÀÍÈß | | 241.53
|
| ÄÆÅÑ (ÒÀÁ ¹28 ) | SCHERING ÃÅÐÌÀÍÈß | | 592
|
| ÄÈÁÈÊÎÐ (ÒÀÁ 0,25 Ã ¹60 ) | ÏÈÊ-ÔÀÐÌÀ ÎÎÎ ÐÎÑÑÈß | | 168.43
|
| ÄÈÑÏÎÐÒ (ËÈÎÔ. Ä/ÏÐÈÃ. Ð-ÐÀ Â/Ì, Ï/Ê ÂÂÅÄ. 500 ÅÄ ÔË ) | ÈÏÑÅÍ ÁÈÎÔÀÐÌ ÂÅËÈÊÎÁÐÈÒÀÍÈß | | 14300
|
| ÄÈÔËÀÇÎÍ (ÊÀÏÑ. 150ÌÃ ¹1 ) | KRKA/ÂÅÊÒÎÐ ÑËÎÂÅÍÈß/ÐÎÑÑÈß | | 193.56
|
| ÄÈÖÈÍÎÍ (ÀÌÏ 125ÌÃ/ÌË 2ÌË ¹50 ) | LEK ÑËÎÂÅÍÈß | | 418.51
|
| ÄÈÖÈÍÎÍ (ÒÀÁ 250ÌÃ ¹100 ) | LEK ÑËÎÂÅÍÈß | | 316.64
|
| ÄÎÍÀ (ÀÌÏ 400ÌÃ 2ÌË ¹6 ) | ROTTAPHARM ÈÒÀËÈß | | 862.16
|
| ÄÎÍÀ (ÏÎÐ. 1,5 Ã ¹20 ) | CSC/ROTTAPHARM ÈÒÀËÈß | | 862.16
|
| ÄÎÍÎÐÌÈË (ÒÀÁË Ï/Î 15ÌÃ ¹30 ) | BRISTOL-MYERS SQUIBB ÔÐÀÍÖÈß | | 166.32
|
| ÄÐÀÌÈÍÀ (ÒÀÁ 50ÌÃ ¹10 ) | JADRAN CO./ÂÅÊÒÎÐ-ÌÅÄÈÊÀ ÕÎÐÂÀÒÈß/ÐÎÑÑÈß | | 78.83
|
| ÄÐÀÌÈÍÀ (ÒÀÁ 50ÌÃ ¹5 ) | JADRAN CO. ÕÎÐÂÀÒÈß | | 59.8
|
| ÄÐÀÌÈÍÀ (ÒÀÁ 50ÌÃ ¹5 ) | JADRAN CO./ÂÅÊÒÎÐ-ÌÅÄÈÊÀ ÕÎÐÂÀÒÈß/ÐÎÑÑÈß | | 59.5
|
| ÄÞÑÏÀÒÀËÈÍ (ÊÀÏÑ.ÐÅÒÀÐÄ 200ÌÃ ¹30 ) | ABBOTT ÔÐÀÍÖÈß | | 354.74
|
| ÄÞÔÀÑÒÎÍ (ÒÀÁ Ï/Î 10ÌÃ ¹20 ) | ÝÁÁÎÒÒ ÁÈÎËÎÄÆÈÊÀËÇ Á. Â. ÍÈÄÅÐËÀÍÄÛ | | 420.96
|
| ÆÀÍÈÍ (ÄÐÀÆÅ ¹21 ) | SCHERING AG ÃÅÐÌÀÍÈß | | 522
|
| ÇÀÌÅÍÈÒÅËÜ ÑÀÕÀÐÀ (ÐÈÎ GOLD ¹1200 ) | ÑÂÈÒ ËÀÉÔ ËÒÄ ÊÈÒÀÉ | | 44.65
|
| ÇÀÌÅÍÈÒÅËÜ ÑÀÕÀÐÀ (ÐÈÎ GOLD ÒÀÁ ¹300 ) | ÑÂÈÒ ËÀÉÔ ËÒÄ ÊÈÒÀÉ | | 21
|
| ÇÀÌÅÍÈÒÅËÜ ÑÀÕÀÐÀ (ÐÈÎ GOLD ÒÀÁ. ¹450 ) | ÑÂÈÒ ËÀÉÔ ËÒÄ ÊÈÒÀÉ | | 26.98
|
| ÇÀÌÅÍÈÒÅËÜ ÑÀÕÀÐÀ (ÐÈÎ GOLD ÒÀÁ. ¹650 ) | ÑÂÈÒ ËÀÉÔ ËÒÄ ÊÈÒÀÉ | | 28.33
|